 |
인쇄하기
취소
|
Boryung opens synthesis plant for Fimasartan
Boryung Pharm has completed its synthesis plant for Fimasartan, antihypertensive agent, at Ansan of Kyunggi Province.
A completion ceremony was held on November 6, 14 months after the ground was broken last August.
The plant will start operation from 2011 to produce the bulk materials of Fimarsatan worth 130 billion a year.
Boryung is expected to complete Phase 3 clinical trial of Fima...
A completion ceremony was held on November 6, 14 months after the ground was broken last August.
The plant will start operation from 2011 to produce the bulk materials of Fimarsatan worth 130 billion a year.
Boryung is expected to complete Phase 3 clinical trial of Fima...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.